2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow H3B-6527: new trials by email Literature Review of H3B-6527 trials Research Report on H3B-6527
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Food-Effect of H3B-6527 H3B-6527 - Healthy Participants | Phase 1 | Completed | Eisai Inc. | 17 | 2017-12-27 | 2018-02-07 |
| Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma H3B-6527 - Advanced Hepatocellular Carcinoma, Hepatocellular Carcinoma | Phase 1 | Completed | H3 Biomedicine Inc. | 128 | 2016-12-28 | 2023-11-13 |
Carcinoma, Hepatocellular (1) · Liver Neoplasms (1)
Eisai Inc. (1) · H3 Biomedicine Inc. (1)
United States (2) · Belgium (1) · Canada (1) · France (1) · Italy (1) · Russia (1) · Singapore (1) · South Korea (1) · Spain (1) · Taiwan (1) · United Kingdom (1)
2016 (1)